Recombinant ITGAL (Efalizumab Biosimilar) anticorps

N° du produit ABIN5668045

L’anticorps Lapin Chimeric anti-ITGAL (Efalizumab Biosimilar) a été validé pour BR et FACS. Il convient pour détecter ITGAL (Efalizumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant ITGAL (Efalizumab Biosimilar) anticorps (ABIN5668045)

Antigène: ITGAL (Efalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Chimeric

Conjugué: Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé

Application: Blocking Reagent (BR), Flow Cytometry (FACS)

Clone: Hu1124

Détail du produit anti-ITGAL (Efalizumab Biosimilar) anticorps

Fonction: Anti-CD11a [hu1124 (Efalizumab)], Rabbit IgG, kappa

Specificité: Binds to human LFA-1.

Attributs du produit:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Pureté: > 98 % as determined by SDS-PAGE

niveau d'endotoxine: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogène: Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Isotype: IgG kappa

Information d'application

Indications d'application: Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

Commentaires:

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur ITGAL (Efalizumab Biosimilar)

Antigène: ITGAL (Efalizumab Biosimilar)

Classe de substances: Biosimilar

Sujet: LFA-1, integrin alpha L

UniProt: P20701